Myasthenia gravis trials in Sweden

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  Where

  Solna

  Age

  18 years and over

  People

  199 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT04951622 · EU 2023-504152-97-00
• Phase 3Taking people
  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Where

  Danderyd, Goteborg, Karlstad

  Age

  18 years and over

  People

  264 worldwide

  Run by

  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  See details and how to joinNCT06463587 · EU 2023-507746-83-00
• Phase 1/2Not yet taking people in Sweden
  A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and immune response of single and multiple ascending doses of TOL2 (Immune Tolerising Agent) in patients with generalised myasthenia gravis

  Where

  Huddinge

  Age

  18 years and over

  People

  55 worldwide

  Run by

  Bonsai Biotherapeutics AB

  See details and how to join2024-515627-10-00 · EU 2024-515627-10-00